RNA polymerase I has been used for transcription of Influenza hemagglutinln (HA) cDNA precisely linked In the anti-sense configuration to both mouse rDNA promoter and terminator segments. In transcription reactions based on Ehrllch ascltes cell nuclear extracts, specific uniform RNA products are synthesized In high rates, that are comparable to original rDNA template transcriptions. Primer extension reactions show the 5' ends of these RNA transcripts to be located exactly at position +1, corresponding to the 5' end of negative strand HA viral RNA. RNA 3' ends in a first series of constructs were found extended beyond the accepted location of pre-rRNA 3' ends, in using both hybrid cDNA and original rDNA templates. But upon deletion of six basepairs from the rDNA termination region RNA polymerase I transcription has been adapted to yield correctly terminated Influenza viral RNA In vitro. This result has been confirmed In an In vivo experiment via synthesis of an anti-sense viral RNA molecule containing the chloramphenlcol acetyltransferase (CAT) gene, which In turn is recognized at Its terminal sequence by viral RNA dependent RNA polymerase for plus strand mRNA synthesis and expression of CAT activity.
INTRODUCTION
Transcription of ribosomal RNA (rRNA) genes is catalysed by RNA polymerase I (1). Corresponding promoter sequence elements have been demonstrated immediately upstream of the initiation point for 45S precursor rRNA (2-4), but their exact boundaries are not yet precisely defined. One controversial point concerns the possibility of regulatory elements overlapping distal coding sequences, up to approximately position +10 (5, 6) . Among the upstream control elements, a specific sequence around position -165 including several transcription factor binding sites, has been studied in detail in the mouse system (7) (8) (9) (10) . Surprisingly, this sequence element bears some resemblance to distal terminator elements and contains a Sail restriction site, too. Accordingly it has been termed T o (11) .
While initiation of RNA polymerase I transcription appears to be roughly similar in its requirements to RNA polymerase II initiation, the molecular events resulting in specific termination of pre-rRNA transcripts are clearly different. The entire prerRNA sequence extends beyong the coding sequence of the mature 28S rRNA by 565 nucleotides (in the mouse system; 12). Ttiis point is 22 bp ahead of the first 18 bp Sal box element which belongs to a conserved cluster of eight such sequence repetitions within positions +587 to +1178, again in relation to the 3' terminal 28S coding position in the mouse system. These elements have been found to be essential for termination and to serve as binding sites for termination factor TTF-I (13), as a tight series they may also constitute a replication barrier protecting rDNA transcription against oppositely moving replication forks (14) . It was also shown by nuclease SI analysis that the 3' end of rRNA precursor molecules appears to be the product of a two-step process: a primary termination reaction only 12 nucleotides upstream of the first Sal box (final 11 bp remaining untranscribed) is followed by a specific trimming reaction during which 10 nucleotides are removed, and a secondary 3' end of the pre-rRNA molecules is resulting in that more upstream position (15) .
RNA polymerase I transcription has not so far been used in hybrid constructions for expression of foreign RNA molecules. Since the 5' cap-structure and 3' poly-A tail are missing from the resulting transcription products such RNA molecules could not function as messenger RNAs, but because of their structure might be adapted to serve as viral RNA molecules if expressed from corresponding cDNA fragments inserted between rDNA promoter and terminator segments. Since at least most of the promoter and terminator elements appear to be located in external positions relative to the insert, this may be a feasible approach to the expression of viral RNA molecules and would have the advantage of the high rate of transcription expected for an rRNAderived system. As an example for a negative strand vRNA expression by RNA polymerase I transcription influenza viral HA cDNA was chosen as an insert.
MATERIALS AND METHODS

Plasmid constructions
In addition to standard vectors, several derivatives of a basic construct, pHK236 (M.Kroger, unpublished), have been used as plasmid vector DNAs for controlled, IPTG dependent expression. In pHK236, which contains the lacV^-gene, a synthetic p* To wbom correspondence should be addressed promoter is followed by a standard multilinker, and two terminators derived from the rrnB gene of E.coli (see pJF118, (16) ) complete the expression cassette within a pAT153 type plasmid.
Plasmid template constructions included mouse rDNA promoter and terminator segments: positions -254 to -1, and +1 to +179 relative to precursor rRNA transcription start and proposed stop positions (or +566 to +745 relative to the 28S rRNA 3' end in the case of the terminator segment), respectively. These segments were arranged to flank hybrid cDNA from human influenza RNA segment 4 (hemagglutinin) of the two influenza virus isolates A/Victoria/3/75 and A/Aichi/2/68 (H3N2; kindly provided by W. Fiers, Gent). Viral DNA inserts included the complete hemagglutinin (HA) segment of 1765 bp (pHL746) or internal deletions thereof: pHL757 to pHL759, see Fig. 1 . In reconstructing the border regions by oligonucleotide synthesis slight variations were introduced at positions 24 and 30 (TTTAAATACTAG.T instead of TTTAATTACTAAT), and 1749/1750 (AATATT instead of AATTAT) of the HA vDNA sequence for the insertion of restriction sites. Also, the sequence upstream of the first Sal box was slightly varied in pHL746 (but not in the pHL832 to pHL880 series) to take into account the consensus of all eight Sal box segments, see Fig. 6B .
In pHL926 the chloramphenicol acetyltransferase (CAT) gene was inserted as a coding substitute exactly between the translation initiation and stop codons of the hemagglutinin reading frame, in anti-sense direction relative to RNA polymerase I transcription. A mouse ribosomal DNA clone with extensive rDNA internal deletion (pPTBH: rDNA minigene) was obtained from I. Grummt (17) .
In vitro transcription
Ehrlich ascites cells grown in the mouse peritoneal cavity were cultured in RPMI medium complemented with 5% of newborn calf serum. Cells were harvested at a density of 1 -1.2 X lC^/ml. S-100 extracts prepared according to Weil et al. (18) , and nuclear extracts according to Dignam et al. (19) were standardized in their transcription activity using the pPTBH: rDNA minigene template. For in vitro transcription experiments, 30 ng of template DNA were incubated in a final volume of 50 /tl in the presence of a mixture of nuclear and S-100 extracts. Reaction mixtures contained 12 mM Hepes (pH 7.8), 85 mM KC1, 0.12 mM EDTA, 5 mM MgCl 2 , 10 mM phospho-creatine (Sigma), 0.66 mM each of ATP, CTP and GTP, 12.5 pM of UTP, and 3 /*Ci of [alpha-^Pl-UTP (3000 Ci/mMol). Reaction mixtures were incubated for 60 min at 32°C Synthesis was terminated by addition of 200 mM sodium acetate (pH 5.5), 0.4% NaDodSO 4 , and 50 /ig of tRNA. RNAs were extracted with phenol and chloroform, precipitated with isopropanol, and fractionated on 6% denaturing acrylamide gels together witĥ P-labelled DNA size markers.
Primer extension analyses of RNA 5' ends
Primer extension analyses of RNA molecules transcribed in vitro, and of viral RNA from strain A/Victoria/3/75 isolated from embryonated eggs were performed to determine the 5' ends of various transcripts, with influenza vRNA serving as a control.
To samples containing the RNA products 10 mM vanadyl ribonucleoside complex and 1 ng of S'-^P-labelled primer oligonucleotide (5'-pTGGGCCTGCCAGAGAGG-3\ specific activity 0.5 X 10 6 cpm/ng oligonucleotide) were added, the mixtures were phenol/chloroform extracted and isopropanol precipitated. Dried pellets of nucleic acids were dissolved in 25 pi of hybridization buffer (80% deionized formamide, 40 mM Pipes, pH 6.4, 0.4 M NaCl, 1 mM EDTA), denatured at 80°C for 5 min and incubated at 37°C for 3 hours. After hybridization the samples were precipitated again and dissolved in 25 /J reverse transcriptase reaction mix containing 80 mM Tris-HO, pH 8.3, 10 mM MgCl 2 , 80 mM KC1, 4 mM DTE, 0.5 mM each of dATP, dCTP, dGTP, TTP and 15 u of AMV reverse transcriptase (Boehringer, Mannheim). The primer extension reaction mixture was incubated at 37°C for 40 min, and the reaction was stopped by incubation at 65 °C for 5 min and further treated with 1 /tg RNAse A (DNAse free) at 37°C for 20 min. Newly synthesized cDNA was purified by phenol/chloroform extraction, precipitated with isopropanol, dissolved in 100 /tl deionized water and again isopropanol precipitated.
The primer extension products were resolved by 6% polyacrylamide/8 M urea gel electrophoresis, with a standard Sanger sequencing ladder (20) of the corresponding M13 clone primed with the same 5'-labelled oligonucleotide as used in the reverse transcriptase reaction. The resulting 32 P-labelled products were visualized by autoradiography.
As a control a similar primer extension reaction was performed using influenza viral RNA (prepared as a mixture of eight RNA segments from influenza A/Victoria/3/75) isolated from embryonated eggs, again in comparison with a corresponding sequencing ladder.
Nudease SI mapping of RNA 3' ends
In vitro synthesized transcription products have been hybridized against surplus amounts of a specific DNA fragment spanning the HA cDNA/rDNA 3' boundary region, between Spel and SaR restriction sites (177 bp). Upon DNA denaturation at 80°C hybridization was carried out for 4 hours in 25 pi of hybridization buffer (80% formamide, 40 mM Pipes, pH 6.4, 0.4 M NaCl, 1 mM EDTA) at 30°C, i.e. 3°C above the melting point of the DNA fragment as determined under these conditions. For nuclease SI reaction the hybridization mixture was diluted into cold 225 pi SI buffer (30 mM Na-acetate, pH 4.5, 0.3 M NaCl, 3 mM ZnCy. and after addition of 384 u SI nuclease (Pharmacia) incubated at 21 °C for 60 minutes. After phenol extraction, precipitation of protected heteroduplex fragments and RNAse treatment an oligonucleotide was added for primer extension DNA synthesis by AMV reverse transcriptase (^P-TGGCACCGCATGATGTC-S', homologous to positions +1625 to +1642 of HA vRNA), and after denaturation the reaction was started in hybridization buffer at 30°C under conditions as described above. The complete procedure was also done in parallel for total influenza viral RNA (mixture of eight segments). For a Sanger sequencing ladder the same primer was used together with an M13mpl8 template DNA covering the same region.
RNA product ligation by T4 RNA ligase
In vitro synthesized transcription products have been treated in 25 pi ligase buffer (50 mM Tris-HCl, pH 8.0, 10 mM MgClj, 10 pg/ml BSA, 25% polyethylene glykol PEG 8000) with 40 pM ATP and 5 u T4 RNA ligase at 25°C (21) . After phenol extraction and precipitation first-strand DNA synthesis was initiated with 250 u of AMV reverse transcriptase (Boehringer) in the presence of 100 u RNAsin as described above, using oligonucleotide 5'-TGGGCCTGCCAGAGAGG-3' complementary to positions +80/+63 in the HA transcripts for starting that reaction in a volume of 20 /d (5 mM MgCl 2 ; 50 mM KC1; 10 mM Tris HCl, pH 8.3; 1 mM dATP, dCTP, dGTP, dTTP, each; 0.75 jtM oligonucleotide). After inactivation of the enzyme at 99°C the reaction volume was increased to 100 pi and converted into PCR conditions (final concentrations: 2 mM MgCl 2 ; 50 mM KC1; 10 mM Tris HCl, pH 8.3; 0.2 mM dATP, dCTP, dGTP, dTTP, each; 0.15 /iM oligonucleotides I and II, each; 2.5 u Taq polymerase per 100 /tl), including addition of the upstream primer as described above, homologous to positions +1625 to +1642 of HA vRNA. After 35 cycles of amplification in a Perkin Elmer thermocycler DNA products have been isolated, cleaved with restriction endonucleases appropriately and cloned into pUC19. 32 clones have been isolated and sequenced across their 3' end/5' end fusion points. CAT assays were performed as described by Gorman et al. 
Lipofektin DNA transfection and CAT assay
RESULTS
Cell-free transcription of rDNA/HA cDNA template DNAs by RNA polymerase I We have constructed a hybrid mouse RNA polymerase I transcription system for in vitro synthesis of influenza hemagglutinin (HA) vRNA. For that purpose the complete HA cDNA (1765 bp) was fused exactly between a mouse rDNA promoter sequence extending from -254 to -1 relative to the startpoint of the 45S pre-rRNA (12) , and a hybrid mouse rDNA terminator sequence containing two rDNA terminator signals Ti and T 2 with a stan-dard 55 bp interval (positions +566 to +745 relative to the 3' end of 28S rRNA). DNA fragments extending across the two fusion points had to be reconstructed by oligonucleo-ti.de synthesis, and two point mutations each in the HA cDNA sequence approximately 25 bp from both ends (see Methods) allowed introduction of extra cleavage sites, including an Spel sequence close to the AUG-initiator sequence, i.e. in anti-sense direction near the vRNA 3' end. In addition to full size HA cDNA/rDNA plasmids (such as pHL746) shorter versions have been created with internal deletions of different lengths, see Fig. 1 .
In a cell free transcription system based on nuclear extracts from Ehrlich ascites cells (1, 12, 19) each of these constructs was expected to generate two specific transcripts terminated at each of the two terminators 55 bp apart on the template DNA. As shown in Figures 2A and 2B three distinct transcription products are observed in each of these hybrid in vitro transcription systems. Since the template DNAs have been linearized at downstream restriction sites, a third signal will result from run-off transcription and will represent the fraction of transcription reactions which did not undergo termination. Viral RNAs or deletion derivatives thereof appear to be transcribed in high numbers and from a unique initiation site within the hybrid promoter. Also, termination reactions seem to occur in a precise and specific manner, since RNA transcripts are of sizes predicted by the lengths of the respective HA cDNA templates, and each pair displays a constant difference in length reflecting the distance of 55 nucleotides between the two terminator signals. Similarly, the sizes of the run-off transcripts are also in accordance with the restriction sites chosen for linearization of the template DNAs (pHL759/Pstl is expected to yield a product 518 nucleotides in length, pHL758/PM DNA: 638 nucleotides, pHL757/Ps/I DNA: 380 nucleotides). While most of the in vitro transcription reactions have been done with shorter cDNA templates for better product analyses, full-size HA cDNA templates of 1765 basepairs similarly gave rise to three clear signals (Fig. 2 B) .
To compare the efficiency of RNA polymerase I transcription of one of the hybrid templates (pHL759) versus an original rDNA minigene construct (pPTBH; see 17) roughly similar in size (transcripts of 324 versus 385 nucleotides) we used both templates together in competition assays. In several such transcription experiments equivalent amounts of template DNAs (30 ng in individual reactions and 2 X15 ng in mixed reactions) or other ratios were mixed before adding S-100/nuclear extracts to start the reaction. The result of one of these experiments is presented in Figure 3 . Both pPTBH linearized with EcoRI and pHL759 cleaved with Pstl resulted in a characteristic set of three product RNA bands. In the reaction shown the set of three pPTBH transcripts migrated aberrantly slowly (but distinctly separated from the pHL759 products) in gel electrophoresis, probably due to insufficient denaturation of RNA secondary structures.
Based on this and a series of other competition experiments it can be concluded that pHL759 DNA is able to compete with original rDNA minigene templates for factors needed for specific initiation and termination of transcription by RNA polymerase I.
Analysis of the vRNA transcript 5' ends
To determine whether the mouse hybrid rDNA promoter is able to initiate transcription of HA viral RNA at the correct startpoint position +1, a primer extension analysis was performed using the mixture of in vitro RNA transcription products. This analysis yielded a single primer extension product for all of the in vitro transcribed RNA molecules of template pHL759 (see lane 1 in Fig. 4A ). The unique transcription start site for all three transcription products, as determined from these primer extension analyses, is indicated by an arrow in Figures 4A and 4B . The position at which all transcripts initiate corresponds exactly to the +1 position as known for original rDNA templates, and is identical with the 5' end of influenza viral RNA.
The 5' terminus observed in a control primer extension reaction for authentic influenza HA vRNA yields the same position for the segment 4 (HA) 5' end, see lane 2 in Fig. 4B . Both reactions are controlled using sequencing ladders obtained from corresponding M13mpl8 clones, initiated with the same 32 Pend-labelled oligonucleotide as used in the primer extension reactions. The same unique initiation point has been confirmed in parallel reactions for two other of the hybrid HA cDNA templates including full-size pHL746 (not shown). Therefore, we conclude that foreign RNA molecules can be produced in vitro with exact 5' termini in hybrid RNA polymerase I transcription.
Analysis of the vRNA transcript 3' ends
For an exact determination of the 3' ends of RNA polymerase I transcription products in vitro, nuclease SI analyses have been performed. For that purpose an excess of a specific 177 bp DNA fragment extending across the expected T^ 3' ends and up to the SaR restriction site within Tl (Fig.l) has been used for hybridization of in vitro synthesized vRNAs. Following treatment with nuclease SI under mild conditions (e.g. for 60 min at 21 °C; 1.5 u SI per /*1), SI-resistant heteroduplexes have been precipitated and after denaturation were used in a primer extension reaction along the complementary DNA strand. After incubation with nuclease SI for degradation of single-stranded DNA tails the resulting 5' end of hybridized DNA strands was expected to be equivalent to the 3' end of the original vRNA transcript terminated at Tj. For comparison with the template sequence a sequence ladder initiated with the same 32 P-5'-labelled primer nucleotide was electrophoresed adjacent to the primer extension products. Also, a control experiment using original vRNA molecules of influenza virus (mixture of eight segments) has been done resulting in the expected 3' position (not shown). Altogether two signals are expected in these analyses, see Fig. 5 . One should originate from the mixture of Tyterminated transcripts, and a second one can be predicted at the SaR cleavage site, since both T 2 -terminated as well as runoff transcription products extend beyond the (first) SaR DNA recognition sequence; it serves as a kind of internal control. That latter signal is indeed observed at the cleavage position within the SaR sequence (and in small part immediately below) while the dominant lower signal representing the T, -terminated vRNAs is observed at position +572, seven nucleotides beyond the expected 3' terminal position at +565. This position is, therefore, located within the adjacent rDNA sequence, at the distal end of a U 6 sequence (and not proximal to it), 15 bp from the Sal box upstream boundary. Minor amounts of reaction products are observed for position +571, and with increased temperatures or S] enzyme concentrations, the primer extension signal becomes spread over several more proximal positions of that stretch of dAg/rUs hybrid sequence (T 6 in the sequencing ladder of Fig. 5 ; not shown) indicating its instability against such SI treatment under other conditions than those used in the definite experiments.
For confirmation of the result obtained for the 3' ends of RNA products in RNA polymerase I transcription, we turned to another, independent technique. T4 RNA ligase treatment was used to convert RNA transcripts in part into circular monomer or linear dimer products via ligation of their 5' and 3' ends. Following first strand DNA synthesis by AMV reverse transcriptase, PCR amplification with a pair of primers oriented across the ligation bridge (i.e. towards both ends of the primary transcript) was used for getting increased amounts of the specific RNA bridge sequences that could be cloned and sequenced. In a series of 32 individual clones isolated and sequenced the 5' terminal nucleotide as determined above was observed ligated to either Tj or T2-terminal sequences. In both groups a clear majority of 3' terminal sequences (12 out of 19, and 13 out of 13) extended beyond the expected 3' ends and well into the consecutive series of six or twelve uridine residues, respectively, but never across into further distal regions. Even though this RNA ligation technique due to RNAse trace activities remaining in nuclear extracts did not yield unequivocal results with regard to the exact location of the 3' ends it is certainly supporting the result of the nuclease SI determination, this time also including termination at T 2 , in an undisturbed pre-rRNA termination reaction. In both cases a likely interpretation of the results presented is the lo-cation of the RNA 3' end at the most distal residue in both series of uridines, i.e. in pHL757 DNA seven nucleotides beyond the expected T t pre-rRNA 3' position according to published data. Because of these results in a second series of hybrid viral rDNA clones the 3' fusion sequence between HA cDNA and the Sal box upstream region has been changed accordingly, both into authentic T! rDNA (pHL880) or unchanged HA cDNA/rDNA Hg pHL926 DNA in 60 y.% Lipofektin from t_ 3h to t^ following infection with influenza strain: A/Asia/57 at moi: 1 from t_5), to t.^ in PBS, and a recovery period in DMEM medium from t_ 4h to t_ 3h . Cellular extracts have been prepared for CAT assay at (1) t 3h , (2) t, i5h , (3) tg,, and (4) t nh after Lipofektin treatment. Controls include (5) cells infected by influenza, but not transfected, (7) DNA transfected but mock infected, and (6) without either treatment, in every case isolated at t, lh . The control lane (c) marks the position of chloramphenicol acetyltransferase reaction products. fusion (pHL835), and by deletion of the dT 6 stretch coding for the 3' rU 6 extension (see pHL832 in Figs. 1 and 6B) . In in vitro transcription with RNA polymerase I containing nuclear extracts pHL832 transcripts proved to be terminated at unique positions for T] and T 2 , approximately 6 nucleotides shorter than transcripts obtained from undeleted pHL835 or pHL880 DNAs (Fig. 6A) . hi this separation of RNA molecules pHL879 transcripts (an aberrant 1 bp insertion clone observed in oligonucleotide based constructions) served as an internal standard to prove that differences even as small as one nucleotide can be detected, and as a measure for the 185/179 and 242/236 nucleotide bias in transcripts expected for pHL835 and pHL832 T] and T 2 termination, respectively. The termination reaction appears not to be severely influenced in its efficieny or precision by deletion of six basepairs in pHL832 or other variations in that Sal box upstream region, including the deviations between pHL835 and pHL757, or between authentic rDNA templates and hybrid DNA sequences. The position of the RNA 3' end for -terminated pHL832 transcripts has been determined using the nuclease SI method and has been found to be located at position 179, i.e. exactly at the 3' end of this shorter version of the inserted HA cDNA sequence (not shown).
In vivo transcription of pseudo-viral CAT RNA
For an in vivo confirmation of the results achieved with transcription of viral cDNA molecules in vitro we constructed a reporter gene version of hybrid HA cDNA by precisely exchanging the HA coding region for that of chloramphenicol acetyltransferase, i.e. retaining the untranslated HA viral cDNA terminal regions (unchanged from pHL832) between the CAT gene sequence and DNA promoter and terminator elements, respectively (Fig. 1) . In its general design, therefore, the CAT reading frame in pHL926 is inserted in anti-sense orientation with regard to the direction of transcription and is expected to give rise to an anti-sense CAT RNA upon transfection into murine cells and transcription by RNA polymerase I.
RNA molecules of this character cannot give rise to CAT activity, but upon superinfection by influenza virus are expected to yield plus strand mRNA molecules according to the cap- snatching mechanism of viral RNA polymerase transcription (23) . This result is specific for influenza RNA type molecules and depends on viral polymerase recognition of terminal 'promoter' sequences of such RNA species. Upon transfection by pHL926 DNA and infection by influenza virus of murine B82 cells CAT activity has indeed been observed in cellular extracts, dependent on both steps of minus strand and plus strand RNA synthesis, and increasing during viral infection periods (Fig. 7) . These results suggest that viral RNA molecules can indeed be transcribed from hybrid cDNAs by RNA polymerase I with perfect ends, in vivo as well as in vitro, and be recognized by viral RNA polymerase for specific plus strand RNA synthesis.
DISCUSSION
Synthesis of hybrid ribosomal precursor RNAs provides an attractive system for the transcription of foreign RNA molecules that are designed not to undergo translation. In particular for minus strand viral RNA molecules RNA polymerase I transcription has the advantage of resulting in RNA species without cap structures and poly-A tails, having instead 5' triphosphate and 3' OH ends of specific, template controlled sequence. The potential of this system could only be realized, however, if both terminal sequences of the inserted cDNA could be chosen freely, i.e. without structural limitations resulting from initiation or termination factor binding sites overlapping with either end of the rDNA coding sequences or restrictions by other steps of the mechanism.
In this report we have used a cell-free hybrid transcription system which consists of murine RNA polymerase I promoter and terminator sequences flanking an inserted full size or partially deleted cDNA of the influenza hemagglutinin gene. The murine rDNA sequences used contain the complete information for a selective transcription of mouse ribosomal precursor RNA as shown with similar internally deleted rDNA templates as controls. The rDNA/HA cDNA hybrid system served as a template for RNA polymerase I in the presence of S-100 and nuclear extracts prepared from rapidly growing Ehrlich ascites cells. The viral RNA transcripts obtained clearly showed that RNA polymerase I in the presence of cellular transcription factors efficiently recognizes the hybrid initiation site and selectively transcribes downstream cDNA sequences of different lengths.
By primer extension analysis it is demonstrated that the RNA polymerase I promoter fused to an HA cDNA sequence initiated transcription at the regular transcription start site (+1) known for rDNA. Due to the template fusion point chosen this position is identical with the first position of viral cDNA. All transcription products, therefore, begin with the correct 5' end of viral RNA molecules, independent of downstream template length. This should in principle be true also for inserted templates other than influenza cDNA.
Competition assays of rDNA between hybrid constructs and authentic rDNAs further indicate that both templates are transcribed in a competitive way, i.e. their transcription draws from the same initiation and termination factors in the extracts used. RNA polymerase I transcription of inserted foreign cDNA templates, therefore, appears to occur following the same initiation mechanism with the same accuracy of initiation, and also in similar yields as observed for original rDNA templates.
Although it has been claimed that sequences downstream of the initiation start site of RNA polymerase I are required for initation of transcription: +1 up to +9 (5), +1 up to +23 (24) , or at least stimulate transcription: +1 to +11 (6) our results show that foreign cDNAs with entirely different nucleotide sequences can indeed be transcribed in the correct way. Because our results have been obtained so far with a single, foreign viral cDNA sequence, influenza HA, some minor downstream sequence requirements for RNA polymerase I cannot be rigorously excluded. Sequence similarities between rDNA and the viral cDNA sequence used occur at positions +1, +3, and +7 (Table  1) . The presence of an adenosine (or purine) in position +1 appears to be a true requirement, but may be quite common for most template constructs being considered and should not cause severe limitations. Conservation of sequence at the two other positions may just be accidental and not in fact be required, since at least one rDNA sequence variant is known, which in position +3 contains a C instead of the common T residue without reduction in transcription rates (6) .
With final proof awaiting a systematic variation of 5' terminal sequence positions we would like to suggest that downstream cDNA sequence restrictions beyond position +1 (purine) are unlikely in the light of these results. Therefore the polymerase I reaction might be useful for transcription of foreign DNA or cDNA templates without any serious sequence limitations at its 5' terminal region.
According to the in vitro transcription patterns with sharp bands for every individual transcript, similarly precise 3' ends of RNA molecules result from RNA polymerase I termination. Both methods used for determining that position: nuclease SI treatment and primer extension, or RNA ligation and outside-in PCR amplification indicate the 3' ends of T! terminated RNA molecules for pHL757 to be located seven nucleotkles more distal than expected. In a further analysis of in vitro transcription product sizes using molecules terminated within authentic rDNA sequence regions (pHL880, pHL879, see Fig.6 ) these transcripts are similarly observed to extend six nucleotides further downstream than presently accepted. In the RNA ligation method equivalent results have been obtained for pHL757, in this case also including termination within the T 2 DNA sequence, which in hybrid constructs is unlikely to be disturbed in any way since the hybrid cDNA sequence is located much further upstream. Together with our own data in carrying out the SI reaction at slightly elevated temperatures we would argue that previous results based on SI nuclease treatment at temperatures above 21 °C may have incorrectly assigned the terminus of pre-rRNA due to uncontrolled S1 degradation extending across that terminal dAg/rUg heteroduplex sequence. This revised assignment of the pre-rRNA 3' end has been further confirmed by deletion of that 6 bp template region in pHL832, which as expected yields transcription products six nucleotides shorter and located exactly at the viral cDNA 3' end. The same is true for several other variations of that revised hybrid cDNA construct (G. Neumann and G. Hobom, unpublished data).
Expression of anti-sense viral RNA molecules by RNA polymerase I in vivo, and their recognition by influenza RNA polymerase for synthesis of plus strand messenger RNA molecules, which only then gives rise to CAT enzyme activity results in further proof for an (at least partially) correct formation of 5' and 3' RNA ends in that transcription. Recognition of terminal 'promoter' sequences by viral RNA polymerase is likely to be very sensitive for nucleotide additions and omissions, or deviations within that sequence (25, 26) , e.g. mRNA molecules of influenza are not recognized for viral RNA amplification, because of their terminal alterations due to cap-snatching and poly-A addition. Different from another technique based on in vitro transcription of influenza RNA (27) the method developed will allow in vivo expression of influenza viral RNA molecules carrying site-directed sequence variations.
